IVF Success Rates in Korea by Age: What the Data Shows
IVF Success Rates in Korea by Age: What the Data Shows
South Korea is one of the most technically advanced countries in the world for in vitro fertilization. Korean fertility clinics consistently report clinical pregnancy rates that match or exceed those of top US and European centers, at a fraction of the cost. But success rates in IVF are not a single number. They vary dramatically by age, and understanding the data by age bracket is essential for setting realistic expectations and making informed decisions.
This guide presents Korean IVF success rate data by age group, compares Korea’s outcomes to the US and UK, explains the medical factors that influence success, and covers the practical considerations of pursuing IVF treatment in Korea.
Korean IVF Success Rates by Age Bracket
The following data represents clinical pregnancy rates per embryo transfer cycle at major Korean fertility centers. Clinical pregnancy is defined as a pregnancy confirmed by ultrasound showing a gestational sac, a more meaningful metric than a positive pregnancy test alone, as it excludes very early biochemical pregnancies.
| Age Group | Clinical Pregnancy Rate (per transfer) | Live Birth Rate (estimated) | Key Notes |
|---|---|---|---|
| Under 30 | 45-55% | 38-48% | Highest success. Excellent egg quality. Fewer cycles needed. |
| 30-34 | 40-48% | 33-42% | Still very strong. Most common age group for IVF in Korea. |
| 35-37 | 32-40% | 26-34% | Noticeable decline begins. PGT-A recommended. |
| 38-39 | 25-32% | 18-26% | Significant quality decline. Multiple cycles often needed. |
| 40-41 | 15-22% | 10-17% | Success still possible but requires realistic expectations. |
| 42-43 | 8-15% | 5-10% | Low but non-zero. Donor eggs dramatically improve odds. |
| 44+ | Under 8% | Under 5% | Own-egg IVF rarely successful. Donor egg is primary option. |
Important context: These ranges reflect data from Korea’s top fertility centers, including university hospital programs and high-volume specialty clinics. Individual clinic results vary. The gap between clinical pregnancy rate and live birth rate accounts for miscarriages, which increase with age (approximately 15% under 35, rising to 40%+ over 40).
Why Age Matters So Much
The single most important factor in IVF success is the age of the eggs. This is not about overall health, fitness, or how young a patient looks or feels. It is about the chromosomal quality of oocytes (eggs), which declines predictably with age due to a biological process called meiotic errors.
At age 30, roughly 70% of a woman’s eggs are chromosomally normal (euploid). By age 40, that number drops to approximately 30-40%. By 43, only about 10-15% of eggs are euploid. Since only euploid embryos can develop into healthy pregnancies, the available “pool” of viable embryos shrinks with each year after 35.
This is why a 31-year-old and a 41-year-old can both produce similar numbers of eggs in a retrieval cycle, yet have vastly different success rates. The younger patient’s eggs are far more likely to produce chromosomally normal embryos.
How Korea Compares to the US and UK
Korean IVF outcomes are competitive with the best centers worldwide. Here is a comparison using approximate clinical pregnancy rates per transfer for the most common age groups:
| Age Group | Korea (Top Centers) | United States (CDC Average) | United Kingdom (HFEA Average) |
|---|---|---|---|
| Under 35 | 40-50% | 40-50% | 32-35% |
| 35-37 | 32-40% | 33-38% | 25-30% |
| 38-40 | 22-32% | 22-28% | 17-22% |
| 41-42 | 12-20% | 12-18% | 8-14% |
| 43+ | 5-12% | 5-8% | 3-8% |
A few observations:
Korea matches the US at the top level. The best Korean fertility centers achieve success rates comparable to leading US programs like CCRM, RMA, and NYU Langone. The difference is cost: a single IVF cycle in Korea costs $4,000-$7,000 versus $15,000-$25,000 in the US (medication included).
Korea outperforms the UK average. The UK’s NHS-funded IVF has historically reported lower success rates, partly due to regulatory limits on the number of embryos transferred and partly due to clinic volume distribution. Korea’s private, competitive market drives clinics to optimize outcomes.
National averages can be misleading. The CDC’s US data and HFEA’s UK data include all clinics, from high-volume centers of excellence to small clinics with lower volumes. Korea’s top fertility centers are more comparable to the top quartile of US clinics, not the national average.
Korea’s Technical Advantages in IVF
Several factors contribute to Korea’s strong IVF outcomes:
High procedure volume: Korea has one of the lowest fertility rates in the world (0.72 births per woman in 2023), which has paradoxically created enormous demand for fertility treatment. Korean clinics perform a very high volume of IVF cycles, and in medicine, volume correlates with expertise.
Advanced embryo culture: Korean labs commonly culture embryos to the blastocyst stage (Day 5-6) before transfer, which allows better embryo selection. Extended culture is technically demanding and requires excellent lab conditions. Korean labs invest heavily in time-lapse incubators (EmbryoScope), clean room infrastructure, and embryologist training.
Preimplantation Genetic Testing (PGT-A): Korea’s fertility centers have widely adopted PGT-A, which screens embryos for chromosomal abnormalities before transfer. PGT-A does not improve the quality of embryos, but it dramatically improves the success rate per transfer by ensuring only euploid embryos are used. This is particularly impactful for patients over 37.
Vitrification (fast-freeze) technology: Korean labs were among the earliest adopters of vitrification for both egg and embryo freezing. Vitrification survival rates at Korean centers exceed 95%, meaning that frozen embryo transfers (FET) achieve outcomes nearly identical to fresh transfers.
Single embryo transfer (SET) protocols: Korean guidelines encourage or require single embryo transfer for patients under 37 to reduce multiple pregnancy risk. Despite transferring only one embryo, success rates remain high due to better embryo selection through PGT-A and extended culture.
What Affects Your Individual Success
While age is the dominant factor, several other variables influence IVF outcomes:
Ovarian Reserve (AMH and AFC)
Anti-Mullerian Hormone (AMH) levels and Antral Follicle Count (AFC) indicate how many eggs a patient is likely to produce in a stimulation cycle. Low ovarian reserve (AMH under 1.0 ng/mL) does not necessarily mean lower quality eggs, but it means fewer eggs per cycle, which reduces the probability of obtaining a viable embryo.
| AMH Level | Expected Response | Implication |
|---|---|---|
| Over 3.0 ng/mL | High responder (15+ eggs) | Excellent prognosis. Risk of OHSS. |
| 1.5-3.0 ng/mL | Normal responder (8-15 eggs) | Good prognosis. Standard protocols. |
| 1.0-1.5 ng/mL | Reduced reserve (5-8 eggs) | May need adjusted protocols. Still viable. |
| 0.5-1.0 ng/mL | Low reserve (2-5 eggs) | Multiple cycles likely needed. Consider mini-IVF. |
| Under 0.5 ng/mL | Very low reserve (0-3 eggs) | Discuss donor eggs. Own-egg possible but challenging. |
Korean fertility clinics typically request AMH, FSH, estradiol, and AFC results before proposing a treatment plan. If you have recent bloodwork, this accelerates the consultation process.
FSH Levels
Follicle-Stimulating Hormone (FSH), measured on Day 2-3 of the menstrual cycle, provides additional information about ovarian function. FSH under 10 mIU/mL is generally considered normal. Levels above 12-15 suggest diminished reserve, and levels above 20 indicate significantly reduced function.
BMI and Metabolic Health
Body Mass Index affects IVF outcomes at both extremes. A BMI over 30 is associated with lower egg quality, reduced response to stimulation medications, and higher miscarriage risk. A BMI under 18.5 can affect ovulation and implantation. Korean clinics may recommend weight management before beginning IVF if BMI is significantly outside the 19-30 range.
Male Factor
Male factor contributes to approximately 40-50% of infertility cases. Severe male factor (very low sperm count, poor morphology, or surgical sperm retrieval) may require ICSI (intracytoplasmic sperm injection), which is available at all major Korean fertility centers. ICSI adds approximately $1,000-$2,000 to the cycle cost in Korea.
Uterine Factors
Uterine fibroids, polyps, adenomyosis, or a thin endometrial lining can affect implantation success regardless of embryo quality. Korean clinics routinely perform a hysteroscopy or saline sonogram before the transfer cycle to identify and address these issues.
Multiple Cycle Planning and Cost Considerations
IVF is frequently not successful on the first attempt. Patients should plan financially and emotionally for the possibility of multiple cycles.
Cumulative Success Rates
The per-cycle success rates listed above represent a single attempt. Cumulative success rates across multiple cycles are significantly higher:
| Age Group | Per Cycle | After 2 Cycles | After 3 Cycles |
|---|---|---|---|
| Under 35 | 40-50% | 64-75% | 78-87% |
| 35-37 | 32-40% | 54-64% | 68-78% |
| 38-40 | 22-32% | 39-54% | 52-68% |
| 41-42 | 12-20% | 23-36% | 32-49% |
These cumulative rates assume each cycle produces transferable embryos, which is not guaranteed, especially for older patients or those with low ovarian reserve.
Cost Per Cycle in Korea
| Component | Cost (USD) |
|---|---|
| IVF cycle (stimulation, retrieval, culture, transfer) | $3,500 – $5,000 |
| Medications (stimulation + support) | $1,000 – $2,500 |
| PGT-A (per embryo, if elected) | $300 – $500 |
| ICSI (if needed) | $1,000 – $2,000 |
| Frozen embryo transfer (subsequent cycle) | $1,500 – $2,500 |
| Embryo freezing (annual storage) | $300 – $500 |
| Total first cycle | $4,500 – $7,500 |
| Subsequent FET cycle | $1,500 – $3,000 |
Compare this to the United States, where a single IVF cycle averages $15,000-$25,000 including medications, and PGT-A adds $3,000-$6,000. A patient who needs three cycles in Korea might spend $15,000-$20,000 total, less than the cost of a single cycle in the US.
Planning for Multiple Trips
A typical IVF process in Korea involves:
Trip 1 (10-14 days): Consultation, baseline testing, ovarian stimulation (8-12 days of injections), egg retrieval, embryo culture, and potentially a fresh embryo transfer on Day 5. Alternatively, all embryos are frozen and the patient returns for a frozen transfer.
Trip 2 (5-7 days, if needed): Frozen embryo transfer cycle. Endometrial preparation (can be started with medications at home), then travel to Korea for monitoring and the transfer procedure. Some clinics can minimize the Korea stay to 3-4 days for the FET itself.
Between trips: Embryo storage in Korea is inexpensive ($300-$500/year) and Korean labs have excellent vitrification protocols.
When to Consider Donor Eggs
For patients over 42, or younger patients with severely diminished ovarian reserve, donor egg IVF may offer significantly better outcomes than using own eggs.
| Scenario | Success Rate per Transfer |
|---|---|
| Own eggs, age 42+ | 5-15% |
| Donor eggs (donor age 20-30) | 55-65% |
Korea has a legal framework for egg donation, though the pool of available donors is smaller than in the US, Spain, or Czech Republic. Korean law requires that donors be between 19 and 35, undergo genetic screening, and receive compensation within regulated limits.
For international patients, coordinating a donor egg cycle in Korea requires additional planning. We can discuss this option during your initial consultation if it may be relevant to your situation.
Choosing a Korean Fertility Clinic
Korea has hundreds of fertility clinics, but quality varies. When selecting a clinic for IVF, consider:
Clinic volume: Higher-volume clinics (1,000+ cycles/year) tend to have more experienced embryologists and better lab infrastructure. Ask for annual cycle counts.
Lab certifications: The Korean Society for Reproductive Medicine (KSRM) certifies labs. Ask whether the lab has current KSRM certification.
Success rate reporting: Korean clinics are required to report outcomes to the KSRM. Ask for age-specific success rates from the most recent reporting year.
English-speaking coordination: IVF involves frequent communication (medication instructions, timing, monitoring results). Ensure the clinic has English-speaking coordinators who are available during your treatment.
University hospital vs. specialty clinic: University hospitals like Severance and Seoul St. Mary’s offer IVF within a full medical setting, which is advantageous for patients with complex medical histories. Specialty fertility clinics may offer more personalized attention and scheduling flexibility.
For patients who want to combine IVF with a thorough health screening, university hospitals can often coordinate both services during the same visit, potentially identifying health issues that could affect fertility or pregnancy outcomes.
Preparing for IVF in Korea
Before your first trip, gather the following:
- AMH, FSH, Estradiol blood tests (drawn on Day 2-3 of your menstrual cycle)
- Antral Follicle Count via transvaginal ultrasound
- Semen analysis for your partner (if applicable)
- Relevant medical history: previous IVF cycles, surgical history, current medications
- Any imaging: HSG results, uterine MRI, etc.
Send these to us and we will coordinate a preliminary consultation with a Korean fertility specialist. The consultation is conducted remotely (via the clinic’s international coordinator), and you will receive a preliminary treatment plan and cost estimate before booking any travel.
Next Steps
IVF is emotionally and financially significant. Having accurate data, especially age-specific success rates, helps you make informed decisions about when to pursue treatment, how many cycles to plan for, and whether Korea’s combination of high-quality care and lower costs makes sense for your situation.
We provide free fertility consultations with no obligation. Tell us your situation and we will connect you with the right Korean fertility center.